Report of Foreign Issuer (6-k)
May 10 2019 - 4:04PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
W
ashington,
D.C.
20549
FORM
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
of the
Securities Exchange Act of 1934
For
the month of May 2019
Commission
File Number: 001-37643
KITOV
PHARMA
LTD.
(Translation
of registrant’s name into English)
One
Azrieli Center, Round Tower,
132
Menachem Begin Road, Tel Aviv 6701101, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Kitov
Pharma
Ltd. (the “Company” or the “Registrant”) is announcing that on May 10, 2019, the Company
issued a press release “
Kitov Receives Notice of Allowance for Additional U.S. Patent Covering its Commercial Product
Consensi™
,” which is attached hereto as Exhibit 99.1.
This
Form 6-K, including Exhibit 99.1, is incorporated by reference into each of the Registrant’s Registration Statements on
Form F-3 filed with the Securities and Exchange Commission on December 12, 2016 (Registration file numbers 333-207117, 333-211477
and 333-215037), the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on
May 20, 2016 (Registration file number 333-211478), the Registrant’s Registration Statement on Form S-8 filed with the Securities
and Exchange Commission on June 6, 2017 (Registration file number 333-218538), the Registrant’s Registration Statement on
Form F-3, as amended, originally filed with the Securities and Exchange Commission on July 16, 2018 (Registration file number
333-226195), and the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on
March 28, 2019 (Registration file number 333-230584).
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
KITOV
PHARMA LTD.
|
|
|
|
May
10, 2019
|
By:
|
/s/
Isaac Israel
|
|
|
Isaac
Israel
|
|
|
CEO
& Director
|
2
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Apr 2023 to Apr 2024